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Christoph Heiner Westphal
The discovery of multiple signaling cascades
downstream of Atm may lead to a clearer understanding
of the diverse defects seen in ataxia-telangiectasia.
These pathways — which include evolutionarily conserved
Chk1 and Atr, and non-conserved p21, p53 and Abl —
guard genomic integrity after DNA damage.
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Ataxia-telangiectasia (AT) is a recessive childhood disease
caused by mutations in the ATM (AT-mutated) gene [1].
Symptoms include neurological abnormalities that cause
unsteady posture (ataxia), dilated blood vessels (telangiec-
tasia), infertility, radiation sensitivity, immune deficien-
cies and  lymphoid malignancies. It appears likely that the
diverse defects seen in ATM null mice [2–5] and humans
with AT [6,7] are phenotypic manifestations of disparate
signal-transduction deficits. This interpretation is
supported by recent evidence implicating p53 [8,9], Abl
[10,11], Chk1 [12–14] and Atr (AT- and Rad3-related
kinase) [15] in a variety of pathways that include Atm.
Mammalian Atm turns out to be a member of a protein
kinase family that includes Atr, DNA-PK (DNA-depen-
dent protein kinase) and FRAP [16], which are related to
Atm by their carboxy-terminal kinase domains. Atm
homologs in other organisms, such as Mec1 and Tel1 of
Saccharomyces cerevisiae, Rad3 of Schizosaccharomyces pombe,
and Mei-41 of Drosophila melanogaster, have shed light
upon diverse functions of this protein [17], the main role
of which appears to be the induction of DNA-damage
responses [6,7,16,18–20]. These damage-control pathways
are induced by both genotoxic insults — such as ionizing
radiation or anti-tumor medications — and the pro-
grammed DNA breaks of meiosis. This is consistent with
the phenotype of AT cells, which show chromosomal
instability and hypersensitivity to agents that cause DNA-
strand breaks.
The description of an irradiation-induced pathway
leading from Atm to p53 [21] provided the first indication
that the diverse disease manifestations seen in AT may
reflect impairment of signal-transduction cascades.
Recent observations support this hypothesis [8–15] and
delineate a number of signal-transduction cascades ema-
nating from the Atm protein kinase. Interestingly, the
Atm signaling cascades involving Chk1 and Atr appear to
be conserved, at least in part, from yeast to mammals, and
are likely to play a central role in the maintenance of
genomic integrity.
Atm, p53 and p21: genetics links old friends
Atm and p53 have been postulated to interact in cellular
growth control, the mediation of cell-cycle checkpoints,
apoptosis and the organismal response to ionizing
radiation [7]. The generation of knockout mice and the
derivation of p53 and/or Atm deficient cells from these
mice [8,9] has made it possible to test these postulated
functions.
Atm-deficient embryonic fibroblasts, derived from ATM
knockout mice, undergo premature growth arrest in
culture, probably because of their increased genomic
instability [2,3,5]. In sharp contrast, fibroblasts deficient in
both Atm and p53 grow rapidly in culture, indicating that
p53 is a prominent modulator of the growth arrest seen in
the ATM null state, and consistent with Atm and p53
being connnected by a linear pathway (Figure 1a). As
ATM and p53 mutant cells are both defective in the DNA-
damage-induced G1/S cell-cycle checkpoint, these two
genes may interact in this pathway as well [7]. Notably,
the irradiation-induced checkpoint defect is no worse in
ATM/p53 double mutant fibroblasts than either single
mutant [9], again consistent with a linear cascade
(Figure 1b), although it is likely that they interact in a
more complex manner than portrayed here. These results
highlight the paradox that Atm may either promote or
inhibit growth, depending on the circumstances, and that
p53 may modulate both of these effects.
Atm and p53 have both been implicated in apoptosis and
in the organismal response to ionizing radiation [7]. Inter-
estingly, ATM mutant thymocytes are only partially resis-
tant to ionizing-radiation-induced apoptosis, whereas p53
and ATM/p53 mutant thymocytes are profoundly resistant.
Furthermore, the increase in p53 protein level that is nor-
mally induced by ionizing radiation is significantly
delayed in ATM mutant thymocytes [8]. These results are
consistent with p53 and Atm being components of an ion-
izing-radiation-induced apoptosis pathway, although in
this case there is substantial non-linearity in the Atm–p53
interactions (Figure 1b). Lastly, ATM mutant mice and
humans are exquisitely sensitive to ionizing radiation.
Here again, p53 has been postulated to interact with Atm
[2,6,7]. Surprisingly, ATM/p53 double mutant mice are just
as sensitive to ionizing radiation as the ATM single
mutants, arguing that the two genes do not interact in
acute radiation toxicity.
A more detailed biochemical understanding of the interac-
tions between Atm and p53 is the goal of intense current
research efforts. These interactions in mammalian cells
are not evolutionarily conserved in yeast, and so must be
necessary only for the subtle control of the DNA-damage
response in higher organisms, or, alternatively, not be
crucial in the organismal DNA-damage response.
Radiation induces an Atm/Abl phosphorylation cascade
The abl proto-oncogene, known to be involved in specific
translocation-associated human tumors, has been impli-
cated in the DNA-damage-induced G1/S cell cycle
checkpoint [22]. As Atm is also necessary for the damage-
induced G1/S cell-cycle checkpoint [7], interactions
between these two genes and their protein products have
been studied in some detail [10,11].
Atm binds to Abl constitutively in human cells via weak
interactions between a proline-rich region of Atm and the
Src-homology 3 (SH3) domain of Abl [11]. Gamma irradia-
tion induces Abl tyrosine kinase activity, which is absent
in ATM null cells of humans [11] and mice [10]. This tyro-
sine kinase activity is dependent upon Atm-mediated
phosphorylation of Abl at Ser465 [10], but it is not clear
whether loss of this phosphorylation is associated with
failure of the G1/S cell cycle checkpoint. These data can
be summarized in a model of the interactions between
Atm and Abl in mammalian cells (Figure 2).
The importance of these biochemical data will likely be
clarified by further work analyzing their functional conse-
quences. It will be especially important to confirm that abl
mutant mouse embyonic fibroblasts are defective in a
G1/S cell-cycle checkpoint, and to analyze the possible
interactions of other proteins with the Atm/Abl signaling
pathway outlined here. As with Atm and p53, Atm–Abl
interactions are not evolutionarily conserved in lower
eukaryotes. This may mean either that these interactions
are not central to DNA-damage responses, or that more
sophisticated regulation is afforded to mammalian cells by
use of this novel pathway.
Atm/Chk1 pathway conserved in yeast and mammals 
The chk1 gene is a central mediator of DNA-damage-
induced cell-cycle checkpoints in S. pombe [23,24]. Chk1
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Figure 1
Pathways linking Atm and p53 in the mammalian DNA-damage
response. (a) Loss of ATM leads to an abnormal accumulation of DNA
damage and so premature growth arrest in both mouse and human
fibroblasts, with concurrent elevation of p21 protein levels. This growth
arrest is alleviated in ATM/p53 double mutant mouse fibroblasts, so
that Atm and p53 can be linked in a pathway. (b) Loss of both ATM
and p53 has no greater effect on the G1/S cell-cycle checkpoint than
loss of either alone. This is again consistent with a linear pathway
(pathway on left). In this case, however, Atm induces p53 activity and
so cell-cycle arrest. In thymocyte apoptosis (pathway on right), ATM
and p53 interact only partially, indicating substantial non-linearity of
this pathway. Note that the actual pathways linking ATM and p53 are
likely to be much more complex, and less linear, than those
presented here.
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Figure 2
The mammalian radiation-induced Atm–Abl phosphorylation cascade.
Atm binds to and phosphorylates Abl upon γ-irradiation. This
phosphorylation makes Abl active as a tyrosine kinase and may, in
concert with other factors, play a role in the DNA damage-induced
G1/S cell-cycle checkpoint. Determining the functional importance of
this pathway in the mediation of the DNA-damage response is the goal
of current research efforts. This pathway, though presented as being
linear here, may well be more convoluted.
Gamma irradiation
Atm
Abl Abl-phosphate
(active tyrosine kinase)
? Other mediators
G1/S cell-cycle checkpoint
Current Biology
?
Dispatch R791
can be placed in a genetic pathway leading from rad3 — the
S. pombe homolog of both ATM and ATR — to cdc2/cyclin B
[18]. This signal-transduction cascade (Figure 3) is essential
for cell-cycle arrest after DNA damage.
Recently, two groups have reported the cloning of
mammalian chk1 [12,13]. Chk1 expression patterns closely
mirror those of ATM in mouse tissues [13], and Chk1
protein expression is dependent upon ATM [12]. As rad3
is the S. pombe homolog of ATM, these results indicate that
the DNA-damage response upstream from chk1 appears to
be substantially conserved from fission yeast to mammals
([12] and Figure 3).
Following DNA damage, Chk1 activity is necessary for
the phosphorylation of the dual-specificity phosphatases
Cdc25A/B/C, thus preventing the activation of Cdc2/
cyclin B — which requires removal of an inhibitory phos-
phate from Cdc2 — and so mitotic entry [13,14], both in
fission yeast and in mammalian cells (Figure 3). These
data indicate that an entire yeast checkpoint signaling
cascade is largely conserved in mammals. Thus, a large
amount of yeast work may help us to understand the
mammalian cell-cycle checkpoint machinery. Moreover,
the extraordinary level of conservation of this pathway
indicates that it may be crucial to the maintenance of
genomic stability.
ATM is necessary for ATR-associated protein kinase activity
Atr is the closest mammalian homolog of Atm [15,25] and
is most related to the S. pombe Rad3 protein kinase, an
important mediator of DNA-damage-induced cell-cycle
checkpoints [16,18]. Hence, a study of the Atm–Atr inter-
action in mammalian cells may shed light upon the mam-
malian DNA-damage response.
Atr protein kinase activity is dependent upon ATM, while
the expression of Atr protein is independent of both ATM
and p53 in mouse testis (M.F. Hoekstra, personal commu-
nication). This observation links the function of two
important checkpoint mediators in a regulatory cascade,
similar to the results obtained with ATM and chk1
(Figure 3). It appears likely that this cascade, involving
the evolutionarily conserved genes ATM and ATR, will
mediate some aspects of the DNA-damage response,
though formal proof of the importance of Atr in this
response awaits studies of ATR null mice.
Loss of Atm affects multiple signaling cascades
The pleiotropic nature of AT may reflect impairment of
diverse signaling networks in the ATM null state. Recent
biochemical and genetic studies indicate that Atm inter-
acts with a number of key regulators of the DNA-damage
response, including p53, p21, Abl, Chk1 and Atr. There
appear to be two classes of Atm-dependent signaling cas-
cades: the first involving non-conserved proteins, such as
p21, p53 and Abl, and the second involving conserved pro-
teins, such as Chk1 and Atr.
The pathways of the latter class are substantially con-
served from yeast to mammals and are likely, therefore, to
be central to any DNA-damage response. By contrast, the
Atm-dependent signal-transduction cascades involving
p21, p53 and Abl are not evolutionarily conserved, and
more detailed study will be needed to establish their func-
tional importance. Elucidation of the precise interaction of
evolutionarily non-conserved cell-cycle checkpoint regula-
tors with well-conserved cell-cycle proteins remains a
major goal of cell-cycle research.
The DNA-damage-induced signal-transduction pathways
linking Atm, p21, p53, Abl, Chk1 and Atr, outlined in this
dispatch, are unlikely to be truly linear. Hence, more sys-
tematic studies of these pathways are needed. These
Figure 3
Conservation of the Chk1 pathway from fission yeast (S. pombe) to
mammals, and interactions between the Rad3 homologs Atm and Atr.
S. pombe components of the DNA-damage-induced cell cycle
response are shown on the left, and their mammalian homologs are
shown on the right. Note that Atm is necessary for Chk1 protein
expression, which, through direct or indirect mechanisms, inhibits
Cdc25, thus preventing Cdc2 dephosphorylation and cell-cycle
progression. It appears that this pathway is substantially conserved
from yeast to mammals, though the precise details of regulation are
different. For example, S. pombe Rad3 has two homologs in mammals,
Atm and Atr. Atm is necessary for Atr-associated protein kinase
activity, but not Atr protein expression. Mammalian cells may regulate
Chk1 activity and cell cycle progression via Atm–Atr interactions
(compare this to the apparent linearity of the Rad3–Chk1 interaction in
S. pombe). Atm/Atr interactions hence appear to represent a variation
on the theme seen in yeast. Note that the actual DNA-damage
response pathway is likely to be more intricate than portrayed here.
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studies should uncover further clues to the pleiotropic
nature of AT, and reveal some of the molecular defects
that underlie carcinogenesis in general. Hopefully, these
insights will lead to novel anti-tumor strategies, and to
improved therapeutic solutions for the many disorders
that plague children with AT. 
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